Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Technology Offers Identification, Genotyping, and Characterization of Emerging Organisms

By LabMedica International staff writers
Posted on 22 Apr 2010
A program with public health applications includes epidemiologic surveillance, monitoring of pandemic diseases, and identification of emerging or previously unknown agents.

The Plex-ID system employs a combination of molecular technologies, including polymerase chain reaction (PCR) for gene amplification and mass spectrometry analysis to characterize rapidly known and unknown organisms. More...
It is designed to address a significant unmet need by providing test results in six to seven hours instead of three or more days as required with current laboratory methods.

Plex-ID, a product of Abbott (Abbott Park, IL, USA), can identify a broad range of bacteria, viruses, fungi, and certain parasites, and provide information about drug resistance, virulence, and strain type. It has the potential to be a powerful and versatile tool for public health laboratories, according to David N. Sundwall, Ph.D., executive director, Utah Department of Health (UDH; Salt Lake City, UT, USA).

"Plex-ID addresses the complex challenges of microbial identification by detecting and characterizing both known and previously unknown organisms found in a variety of specimens," Dr. Sundwall said. "The high-throughput technology offers our laboratory rapid detection and correct identification of a broad range of pathogens."

Dr. Sundwall added that for disease surveillance, the Plex-ID technology would enable public health officials to track emergent strains as they evolve, mutate, and possibly become more dangerous.

Abbott announced that the Utah Department of Health is one of five sites in the United States to participate in Abbott's new Plex-ID Biopreparedness Evaluation Program (BPEP), which involves Abbott, the Association of Public Health Laboratories (APHL; Silver Spring, MD, USA) and five state public health labs. The announcement was made at a ribbon-cutting ceremony for UDH's new multipurpose, state-of the-art Unified State Lab (USL; Taylorsville, UT, USA), a 7525 m2 facility that houses a variety of public-health laboratories.

In addition to Utah, the evaluation program will be conducted at state public health laboratories in Oklahoma, Minnesota, New York, and Virginia. In 2009, Plex-ID was recognized by both the Scientist and the Wall Street Journal as a top scientific innovation of the year.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture, and marketing of medical products, diagnostics, and pharmaceutics.

Related Links:
Abbott
Utah Department of Health
Association of Public Health Laboratories
Unified State Lab


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.